SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 6.02 |
| Enterprise Value ($M) | 6.23 |
| Book Value ($M) | -2.10 |
| Book Value / Share | -0.00 |
| Price / Book | -2.86 |
| NCAV ($M) | -2.10 |
| NCAV / Share | -0.00 |
| Price / NCAV | -2.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -84.90 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.01 |
| Current Ratio | 0.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.03 |
| Assets | 0.03 |
| Liabilities | 2.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -4.24 |
| Net Income | -4.44 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.01 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.04 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| QBIO – Q BioMed Inc. | QRON – Qrons Inc. |
| RAPH – Raphael Pharmaceutical Inc. | RBSH – Rebus Holdings, Inc. |
| RELV – Reliv' International, Inc. |
Financial data and stock pages provided by
Fintel.io